unyango olucacileyo i-cell renal cell carcinoma

Unyango lwe-Clear Cell Renal Renal Cell Carcinoma: Isikhokelo esiBanziUkuqonda iinketho zokunyanga i-cell cell renal cell carcinoma (ccRCC) ibalulekile kwizigulane kunye neentsapho zazo. Esi sikhokelo sinika inkcazo ecacileyo yeendlela zonyango zangoku, ezigxininise kubungqina obusekelwe kubungqina kunye nokunyamekela okujoliswe kwisigulane. Siza kuphonononga amanqanaba ahlukeneyo e-ccRCC kunye nonyango olulungelelanisiweyo olusetyenziswa kwinqanaba ngalinye, kuqaqambisa ukubaluleka kokuxilongwa kwangoko kunye nolawulo olusebenzayo. Le ngcaciso yenzelwe iinjongo zemfundo kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nengcali yezempilo ngezicwangciso zonyango ezilolwakho.

Uxilongo kunye nokubekwa kwe-ccRCC

Ukuxilongwa ngokuchanekileyo kunye nesiteji kubaluleke kakhulu ekunqumeni isicwangciso sonyango esisebenzayo ecacileyo i-cell renal cell carcinoma. Ubuchule bokucinga, obufana ne-CT scans kunye ne-MRI, bubalulekile ekuchongeni ubungakanani bethumba, indawo elikuyo, kunye nokusasazeka okunokwenzeka. I-Biopsies isoloko isenziwa ukuqinisekisa ukuxilongwa kunye nokumisela uhlobo oluthile lomhlaza wezintso, kuquka ubukho be-ccRCC. Iinkqubo zeqonga, ezifana nenkqubo yeqonga ye-TNM, zihlela ubungakanani bomhlaza, eziphembelela izigqibo zonyango. Ukufunyaniswa kwangoko, ngokuhlolwa rhoqo kunye nophando olukhawulezileyo lweempawu, kuphucula kakhulu ukuxilongwa.

Ukuqonda i-TNM Staging System

Inkqubo yeqonga ye-TNM isebenzisa izinto ezintathu ukuhlela ecacileyo i-cell renal cell carcinomaT: Ichaza ubungakanani kunye nobungakanani bethumba eliphambili. N: Ibonisa ukubandakanyeka kwee-lymph nodes ezikufutshane. M: Icacisa ukuba ngaba umhlaza u-metastasized (usasazeka) kwizitho ezikude.Inye yale miba ifumana isigaba samanani (umzekelo, T1, T2, njl.), Ukubonelela ngovavanyo olubanzi lwenkqubela phambili yesifo. Ukudibanisa izigaba ze-T, N, kunye ne-M zibonelela ngenqanaba elipheleleyo lomhlaza.

Iinketho zonyango lwe-ccRCC

Iinketho zonyango ze ecacileyo i-cell renal cell carcinoma ziyahluka kakhulu ngokusekelwe kwinqanaba lomhlaza kunye nempilo jikelele yomguli. Uqhaqho loqhaqho luhlala lulolona nyango luphambili lwe-ccRCC yendawo, ngelixa unyango lwenkqubo, kubandakanywa unyango olujoliswe kuyo kunye nonyango lwe-immunotherapy, luqhele ukuqeshwa kwizifo eziphambili okanye ze-metastatic.

Uqhaqho loKutyandwa

Yendawo yokuhlala ecacileyo i-cell renal cell carcinoma, ukususwa ngotyando lwethumba kwaye okunokuba yinxalenye okanye zonke izintso ezichaphazelekayo (i-nephrectomy engaphelelanga okanye i-nephrectomy enkulu) ngokuqhelekileyo ngumgca wokuqala wonyango. Ukhetho phakathi kwezi nkqubo luxhomekeke kwizinto ezininzi, kubandakanya ubungakanani bethumba, indawo, kunye nempilo yonke yesigulana. Ubuchwephesha botyando obuncinci, obufana notyando lwe-laparoscopic, luya kukhethwa ngakumbi, lunciphisa ixesha lokubuyisela kunye neengxaki ezinokwenzeka.

Unyango ekujoliswe kulo

Unyango olujoliswe kuyo lusebenza ngokuthintela iimolekyuli ezithile ezinegalelo ekukhuleni kwethumba. Iindlela ezininzi zonyango ekujoliswe kuzo zingqineke zisebenza ngokuchaseneyo ecacileyo i-cell renal cell carcinoma, ngokukodwa ezo zijolise kwi-vascular endothelial growth factor (VEGF) kunye nethagethi ye-mammalian ye-rapamycin (mTOR). Imizekelo ibandakanya i-sunitinib, i-sorafenib, i- pazopanib, kunye ne-everolimus. La mayeza angasetyenziswa ngomlomo kwaye ahlala esetyenziswa njengonyango lodidi lokuqala okanye lodidi lwesibini lwe-metastatic ccRCC. Iziphumo ebezingalindelekanga ziqhelekile kwaye zinokwahluka phakathi kwabantu. I-oncologist yakho iya kukubeka esweni ngononophelo ngexesha lonyango.

Immunotherapy

I-Immunotherapy iphakamisa amajoni omzimba omzimba ukulwa iiseli zomhlaza. I-Checkpoints inhibitors, ezifana ne-nivolumab kunye ne-ipilimumab, ivimba i-immune checkpoints, ivumela amajoni omzimba ukuba aqaphele kwaye ahlasele iiseli zomhlaza ngokufanelekileyo. La mayeza asetyenziswa rhoqo kwi-Advanced okanye metastatic ecacileyo i-cell renal cell carcinoma kwaye inokudibaniswa nonyango olujoliswe kuyo kwiziphumo eziphuculweyo. I-Immunotherapy inokuvelisa imiphumo ebalulekileyo yecala, kuquka iingxaki ezizenzekelayo, ezinokufuna ulawulo olusondeleyo lwezonyango.

Unyango ngemitha

Ngelixa ingengonyango oluphambili lwe-ccRCC, unyango lweradiation lunokudlala indima exhasayo ekulawuleni iintlungu ezivela kwi-metastases yamathambo okanye ekunyangeni ukuphindaphinda kwendawo emva kotyando.

Iimvavanyo zeklinikhi

Izigulane ezine ecacileyo i-cell renal cell carcinoma kufuneka ithathele ingqalelo ukuthatha inxaxheba kulingo lwezonyango. Ulingo lwezonyango lunikeza ukufikelela kunyango olutsha oluthembisayo kwaye lube negalelo ekuqhubeleni phambili uphando lomhlaza. Ugqirha wakho unokukunceda ekufumaneni amathuba afanelekileyo olingo lwezonyango. Iziko loPhando ngoMhlaza laseShandong Baofa https://www.baofahospital.com/ izinikele ekuboneleleni ngokhathalelo oluphezulu lomhlaza kwaye yenza uphando olugxile ekuphuculeni iziphumo zezigulane.

Ukubeka iliso kunye nokulandelela

Emva konyango, ukuqeshwa okulandelwa rhoqo kubalulekile ekubekeni iliso ukuphindaphinda okanye ukuphuhliswa kwamathumba amatsha. Izifundo zemifanekiso kunye neemvavanyo zegazi zihlala zisetyenziselwa ukujonga ukuqhubeka kwesifo. Ukubona kwangaphambili ukuphindaphinda kuvumela ukungenelela ngokukhawuleza kwaye kunokuphucula iziphumo.

Uhlobo loNyango	Inkqubo	Inqanaba le-ccRCC	Iimpembelelo eziPhakamileyo
Uqhaqho loKutyandwa	Ukususwa ngokomzimba kwethumba	I-ccRCC yendawo	Iintlungu, usulelo, ukopha
Unyango ekujoliswe kulo	Ukuthintela iimolekyuli ezithile	Metastatic ccRCC	Ukudinwa, isicaphucaphu, uxinzelelo lwegazi
Immunotherapy	Ukuvuselela amajoni omzimba	Metastatic ccRCC	Ukudinwa, ukubetha kwesikhumba, iingxaki ezizimelayo

I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nengcali yokhathalelo lwempilo olufanelekileyo ukuze uxilongwe kunye nonyango lwaso nasiphi na isimo sonyango.